Form 3 filing by Director David J. Endicott shows zero beneficial ownership at the time of the report. This indicates the insider has not yet acquired shares in the open market or through equity grants. Monitor future Form 4 filings for open-market purchases or equity award conversions, which would signal insider conviction. No trading action warranted from this filing alone.
How the stock moved after the report
NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+60- T+0 · Jul 7 $15.37entry
- T+1 · 4mo ago −2.28%α −1.97% · $15.02
- T+5 · 4mo ago −2.15%α −2.70% · $15.04
- T+20 · 4mo ago +24.27%α +22.94% · $19.10
- T+60 · 7w ago +26.68%α +24.47% · $19.47
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Director David J. Endicott filed an initial Statement of Beneficial Ownership (Form 3) with MiniMed Group, Inc. on 2026-07-06, reporting 0 shares beneficially owned. This is a routine securities filing by a new insider/10% owner disclosing their initial ownership position, with no economic impact or trading signal.
Key Facts
- Director David J. Endicott filed Form 3 on 2026-07-06 (period of report: 2026-06-29).
- Endicott reported 0 shares beneficially owned in MiniMed Group, Inc. (MMED).
- The filing includes a Power of Attorney (Ex-24) dated 2026-07-02.
- MiniMed Group, Inc. was previously named MDT Sub Holdings, Inc. (name change 2025-03-20).
Financial Impact
No financial impact, the reporting person holds 0 shares.
Risk Factors
- Zero initial ownership does not imply conviction, wait for insider open-market purchases (Form 4) for a meaningful signal.
- Name change from MDT Sub Holdings, Inc. may reflect a prior restructuring or spin-off, monitor for future filings on corporate history.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 8 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (MMED), Batch item 1 | 0001532133-26-000002 |
| Document: 0001532133-26-000002-index-headers.html | 0001532133-26-000002 |
| Document: 0001532133-26-000002-index.html | 0001532133-26-000002 |
| Document: 0001532133-26-000002.txt | 0001532133-26-000002 |
| 3 Filing (MMED), Batch item 5 | 0001532133-26-000002 |
| Document: 0001532133-26-000002-index-headers.html | 0001532133-26-000002 |
| Document: 0001532133-26-000002-index.html | 0001532133-26-000002 |
| Document: 0001532133-26-000002.txt | 0001532133-26-000002 |
Track record
25 reports on MMED
The track record builds as more bullish or bearish reports settle.
Filters
- Nov 16, 2026today 8-K Mixed 6/10 Entry $18.77 Now $18.65 −0.64% settles Dec 15
- Nov 16, 2026today Press Release Bullish 7/10 Entry $18.81 Now $18.65 −0.86% settles Dec 15
- Nov 6, 202610d ago SC 13G Neutral 4/10 Entry $16.71 Now $18.65 +11.61% settles Dec 7
- Oct 22, 202625d ago SC 13G Neutral 4/10 Entry $18.34 Now $18.65 +1.69% settles Nov 20
- Oct 16, 20264w ago SC 13G/A Neutral 4/10 Entry $17.79 to $18.65 Now $18.65 +4.83% ▲ +4.83% +8.30% vs SPY
- Oct 16, 20264w ago 8-K Neutral 6/10 Entry $17.49 to $17.99 Now $18.65 +6.63% ▲ +2.86% +4.02% vs SPY
- Oct 6, 20265w ago EFFECT Neutral 3/10 Entry $19.64 to $18.85 Now $18.65 −5.04% ▼ −4.02% −0.85% vs SPY
- Oct 1, 20266w ago 3 Neutral 2/10 Entry $19.70 to $18.28 Now $18.65 −5.33% ▼ −7.21% −5.40% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
- Sep 14, 20269w ago 425 Neutral 4/10 Entry $21.97 to $18.80 Now $18.65 −15.11% ▼ −14.43% −16.69% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers